120 related articles for article (PubMed ID: 284401)
21. Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma.
Bloise W; Wajchenberg BL; Moncada VY; Marcus-Samuels B; Taylor SI
J Clin Endocrinol Metab; 1989 Jan; 68(1):227-31. PubMed ID: 2642487
[TBL] [Abstract][Full Text] [Related]
22. The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level.
Green A
Biochem J; 1986 Sep; 238(3):663-9. PubMed ID: 3541915
[TBL] [Abstract][Full Text] [Related]
23. Relation of insulin receptor occupancy and deactivation of glucose transport.
Häring HU; Biermann E; Kemmler W
Am J Physiol; 1982 Apr; 242(4):E234-40. PubMed ID: 7039360
[TBL] [Abstract][Full Text] [Related]
24. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone regulates the glucose transport system in primary cultured adipocytes: different mechanisms of insulin resistance after acute and chronic exposure.
Garvey WT; Huecksteadt TP; Monzon R; Marshall S
Endocrinology; 1989 May; 124(5):2063-73. PubMed ID: 2651092
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.
Roth RA; Cassell DJ; Wong KY; Maddux BA; Goldfine ID
Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7312-6. PubMed ID: 6185950
[TBL] [Abstract][Full Text] [Related]
27. Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.
Elias D; Rapoport M; Cohen IR; Shechter Y
J Clin Invest; 1988 Jun; 81(6):1979-85. PubMed ID: 3290258
[TBL] [Abstract][Full Text] [Related]
28. Effect of Anti-Insulin Receptor Antibody on Insulin Dissociation from IM-9 lymphocytes.
Blackard WG; Ludeman CH
Horm Metab Res; 1981 Sep; 13(9):480-3. PubMed ID: 7028593
[TBL] [Abstract][Full Text] [Related]
29. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
[TBL] [Abstract][Full Text] [Related]
30. Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes.
Foster CM; Hale PM; Jing HW; Schwartz J
Endocrinology; 1988 Aug; 123(2):1082-8. PubMed ID: 3293980
[TBL] [Abstract][Full Text] [Related]
31. Affinity change of the adipocyte receptor fails to alter insulin-stimulated glucose transport.
McCaleb ML; Donner DB
Biochem J; 1982 Jan; 202(1):263-5. PubMed ID: 7044377
[TBL] [Abstract][Full Text] [Related]
32. Antagonistic effects of a covalently dimerized insulin derivative on insulin receptors in 3T3-L1 adipocytes.
Weiland M; Brandenburg C; Brandenburg D; Joost HG
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1154-8. PubMed ID: 2153971
[TBL] [Abstract][Full Text] [Related]
33. Insulin receptor synthesis and turnover in differentiating 3T3-L1 preadipocytes.
Lane MD; Reed BC; Clements PR
Prog Clin Biol Res; 1981; 66 Pt A():523-42. PubMed ID: 6171829
[TBL] [Abstract][Full Text] [Related]
34. Insulin-induced desensitization at the receptor and postreceptor level in mitogen-activated human T-lymphocytes.
Ercolani L; Lin HL; Ginsberg BH
Diabetes; 1985 Sep; 34(9):931-7. PubMed ID: 3928421
[TBL] [Abstract][Full Text] [Related]
35. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.
Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID
Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to insulin receptors.
Van Obberghen E; Kahn CR
Mol Cell Endocrinol; 1981 Jun; 22(3):277-93. PubMed ID: 7018954
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to purified insulin receptor have insulin-like activity.
Jacobs S; Chang KJ; Cuatrecasas P
Science; 1978 Jun; 200(4347):1283-4. PubMed ID: 663609
[TBL] [Abstract][Full Text] [Related]
38. Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor.
Elias D; Maron R; Cohen IR; Schechter Y
J Biol Chem; 1984 May; 259(10):6416-9. PubMed ID: 6725257
[TBL] [Abstract][Full Text] [Related]
39. The underlying insulin receptor in patients with antireceptor autoantibodies: demonstration of normal binding and immunological properties.
Muggeo M; Kahn CR; Bar RS; Rechler M; Flier JS; Roth J
J Clin Endocrinol Metab; 1979 Jul; 49(1):110-9. PubMed ID: 447809
[No Abstract] [Full Text] [Related]
40. Cellular basis of insulin resistance in chronic uremia.
Maloff BL; McCaleb ML; Lockwood DH
Am J Physiol; 1983 Aug; 245(2):E178-84. PubMed ID: 6349382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
